Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. LifeMD, Inc.
  6. News
  7. Summary
    LFMD   US53216B1044


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

LifeMD to Participate in the Stephens Annual Investment Conference

11/16/2021 | 04:06pm EST

NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD) today announced that management will present at the Stephens Annual Investment Conference on Monday, November 29, 2021 and will host one-on-one meetings.

Presentation details are as follows: 

Stephens Annual Investment Conference – Nashville 2021
Date: Monday, November 29, 2021
Time:9:00am CT / 10:00am ET
Webcast Link:https://kvgo.com/stephens/lifemd-inc-2021

The presentation will be available for replay via the link provided and in the Investors section of the company’s website at https://ir.lifemd.com.

About LifeMD

LifeMD, Inc. is a rapidly growing direct-to-patient telehealth company that offers cash-pay virtual medical care across all 50 states. LifeMD’s telemedicine platform enables virtual access to affordable and convenient medical treatment from licensed providers and, when appropriate, prescription medications and over-the-counter products delivered directly to the patient's home. To learn more, go to LifeMD.com.

Cautionary Note Regarding Forward Looking Statements

This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: “believe,” “expect,” “anticipate,” “project,” “should,” “plan,” “will,” “may,” “intend,” “estimate,” “predict,” “continue,” and “potential,” or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition.

Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, “Risk Factors” identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods.

Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation.

Company Contact                                
LifeMD, Inc.        
Marc Benathen, CFO

Investor Relations Contact
Ashley Robinson
LifeSci Advisors, LLC

All news about LIFEMD, INC.
08:01aLifeMD to Participate in the Upcoming February Investor Conferences
01/19LIFEMD, INC. : Regulation FD Disclosure (form 8-K)
01/19LIFEMD : Provides Initial FY2022 Guidance and Announces Preliminary FY2021 Revenues - Form..
01/19LIFEMD, INC. : Results of Operations and Financial Condition (form 8-K)
01/19LifeMD Provides Initial FY2022 Guidance and Announces Preliminary FY2021 Revenues
01/19LifeMD, Inc. Reports Unaudited Revenue Results for the Fourth Quarter and Full Year of ..
01/19LifeMD, Inc. Provides Earnings Guidance for the Year 2022; Provides Earnings Guidance f..
01/18LifeMD to Participate in the Upcoming Virtual BTIG Conference
01/12LIFEMD : Expands Patient Offerings by Acquiring Leading Allergy Telehealth Platform - Form..
01/12LIFEMD, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Sec..
More news
Analyst Recommendations on LIFEMD, INC.
More recommendations
Financials (USD)
Sales 2021 92,9 M - -
Net income 2021 -55,8 M - -
Net cash 2021 35,7 M - -
P/E ratio 2021 -1,76x
Yield 2021 -
Capitalization 105 M 105 M -
EV / Sales 2021 0,74x
EV / Sales 2022 0,57x
Nbr of Employees 56
Free-Float 72,0%
Duration : Period :
LifeMD, Inc. Technical Analysis Chart | LFMD | US53216B1044 | MarketScreener
Technical analysis trends LIFEMD, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 2
Last Close Price 3,43 $
Average target price 15,50 $
Spread / Average Target 353%
EPS Revisions
Managers and Directors
Justin Schreiber Chairman & Chief Executive Officer
Alexander Mironov President
Marc Benathen Chief Financial Officer
Joseph V. DiTrolio Chief Medical Officer-US
Stefan Galluppi Chief Innovation & Marketing Officer
Sector and Competitors
1st jan.Capi. (M$)
LIFEMD, INC.-11.50%105
AMAZON.COM, INC.-16.70%1 408 577
JD.COM, INC.1.48%109 790
ETSY, INC.-35.46%17 914
WAYFAIR INC.-24.90%14 915
ALLEGRO.EU SA-5.56%9 458